Scholars Central

CommentaryPublished 2013

Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency Status Should be Screened in All Vivax Malaria Patients in Thailand Where Severe G6PD Deficiency is Predominant

Authors: Polrat Wilairatana, Noppadon Tangpukdee, Srivicha Krudsood

Tropical Medicine & Surgery

Volume 1 · Issue 1 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Since most G6PD deficiency in Thailand is G6PD Viangchan (which is severe G6PD deficiency), vivax malaria patients coming to seek treatment should be screened for G6PD deficiency before primaquine is given. Primaquine is contraindicated in vivax malaria treatment with severe G6PD deficiency since primaquine may cause massive hemolysis and even death.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalTropical Medicine & Surgery
  • SubjectSurgery
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Polrat Wilairatana”
  • BylineArticles whose byline prints “Noppadon Tangpukdee”
  • BylineArticles whose byline prints “Srivicha Krudsood”